ImmuCell Corporation ICCC

9.93 (0.04) (0.40%) as of 25 Sep
Market cap
$90.6M
P/E
117×
Insider Buys alert about insiders buying in the last 12 month
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 43.18
P/S ratio
2.01 1.59 2.22 2.70 3.16 2.80 2.56 3.52 3.92 2.63
P/FCF ratio
44.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/Operating CF
115.05 (13,568.09) (53.58) (38.67) 103.31 274.58 (753.60) (279.67) 123.76 (67.59)
P/B ratio
2.05 1.53 1.55 1.65 1.86 1.52 1.21 1.78 1.73 1.28
Price to Tangible BV
2.06 1.53 1.56 1.66 1.87 1.53 1.22 1.80 1.75 1.29
EV/Sales
2.20 1.84 2.85 2.94 3.10 2.90 2.53 4.18 4.42 1.84
EV/EBITDA
13.72 44.82 0.00 278.42 21.89 41.57 26.13 504.64 69.66 10.36
EV/Operating CF
24.56 136.47 (10.64) (35.38) 62.55 33.80 148.89 (122.98) 39.19 (78.87)
EV/FCF
48.22 (472.81) (7.58) (9.92) (36.41) (16.40) (49.11) (21.33) (2.79) (4.64)
Quick Ratio
1.82 1.71 0.75 2.46 5.08 4.41 4.17 1.35 2.49 5.64
Current Ratio
4.26 3.41 2.73 4.56 6.42 5.50 5.29 2.50 3.64 6.97
Net Debt/EBITDA
1.19 6.22 (3.65) 22.61 (0.38) 1.45 (0.26) 79.61 7.79 (4.50)
Debt/Assets
21.39% 23.37% 27.32% 22.81% 20.55% 23.54% 21.77% 29.84% 26.11% 12.20%
Debt/Equity
0.34 0.38 0.48 0.34 0.28 0.34 0.29 0.45 0.38 0.15
Asset Turnover
0.63 0.60 0.39 0.42 0.45 0.39 0.38 0.33 0.35 0.49
Operating CF/Net income
(2.38) (0.17) 0.81 0.62 (12.19) (1.29) (0.18) 0.16 (6.99) (0.44)
Capex/Depreciation
(0.44) (0.17) (0.69) (1.59) (1.05) (1.64) (0.41) (1.16) (19.59) (4.43)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
(3.81%) (8.21%) (20.86%) (7.92%) (0.26%) (3.57%) (5.11%) (10.24%) (0.78%) 3.35%
ROA
(2.37%) (4.85%) (13.03%) (5.58%) (0.18%) (2.59%) (3.63%) (6.93%) (0.57%) 2.59%
ROIC
3.19% (2.99%) (9.98%) (4.13%) 0.51% (2.89%) (2.08%) (3.12%) (0.53%) 4.59%
Return on Tangible Assets
(3.06%) (5.99%) (16.57%) (6.34%) (0.19%) (2.78%) (3.60%) (7.77%) (0.53%) 2.30%
Average Days of Receivables
45.14 51.95 45.66 34.57 51.10 42.75 43.55 30.97 47.03 37.95
Research and Development Expense of Revenue
11.00% 14.72% 25.15% 24.20% 21.66% 28.38% 26.87% 32.01% 19.62% 13.04%
Selling, General and Administrative Expense of Revenue
24.43% 21.45% 29.89% 29.37% 21.98% 25.35% 29.19% 34.81% 32.76% 34.43%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01
Share Based Compensation of Revenue
1.07% 1.23% 2.11% 1.43% 0.75% 1.65% 2.28% 3.13% 1.92% 0.71%
Graham Net Nets
0.03 (0.06) (0.19) (0.01) 0.07 0.00 0.10 (0.12) (0.08) 0.37
Graham Number
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.80
Earnings Yield
(1.71%) (5.63%) (15.00%) (5.00%) (0.13%) (2.35%) (3.69%) (6.10%) (0.48%) 2.32%
Free Cash Flow Yield
2.27% (0.25%) (16.94%) (10.98%) (2.70%) (6.32%) (2.02%) (5.57%) (40.41%) (15.02%)
Revenue per Share
3.06 3.24 2.26 2.40 2.53 2.13 2.01 2.00 2.11 2.26
Operating CF per Share
0.27 0.04 (0.60) (0.20) 0.13 0.18 0.03 (0.07) 0.24 (0.05)
Capex per Share
(0.13) (0.06) (0.24) (0.51) (0.34) (0.56) (0.14) (0.32) (3.58) (0.84)
Free Cash Flow per Share
0.14 (0.01) (0.85) (0.71) (0.22) (0.38) (0.10) (0.39) (3.34) (0.89)
Cash per Share
0.42 0.46 0.13 0.75 1.34 1.10 1.29 0.46 0.77 2.51
Shareholders Equity per Share
3.00 3.37 3.23 3.92 4.29 3.92 4.25 3.96 4.77 4.67
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
3.00 3.37 3.23 3.92 4.29 3.92 4.25 3.96 4.77 4.67
Free Cash Flow
1.26 (0.10) (6.56) (5.51) (1.64) (2.71) (0.71) (2.15) (16.54) (3.78)
Working Capital
12.97 10.63 7.27 10.92 13.73 9.95 10.69 3.86 5.44 12.29
Capital Expenditures
(1.21) (0.46) (1.89) (3.96) (2.59) (4.03) (0.94) (1.78) (17.71) (3.56)
Net Current Asset Value
1.47 (2.54) (7.35) (0.49) 4.38 0.07 3.49 (4.57) (3.20) 9.37
EV/EBIT
36.87 0.00 0.00 0.00 231.90 0.00 0.00 0.00 0.00 19.69
Capex to Sales
0.04 0.02 0.11 0.21 0.13 0.26 0.07 0.16 1.70 0.37
Net Profit Margin
(3.76%) (8.14%) (33.05%) (13.43%) (0.41%) (6.66%) (9.44%) (21.13%) (1.61%) 5.33%
Price to Operating Income
33.66 0.00 0.00 0.00 235.96 0.00 0.00 0.00 0.00 28.24
Other line items
Depreciation/Fixed assets
0.13 0.11 0.10 0.09 0.09 0.09 0.09 0.06 0.03 0.08
Cash ROIC
(46.54%) (59.77%) (85.00%) (64.62%) (49.98%) (55.65%) (54.20%) (77.58%) (68.49%) (30.18%)
Accounts Receivable Turnover
7.69 8.90 8.86 8.34 8.57 8.94 10.68 9.65 8.93 11.16
Accounts Payable Turnover
6.80 8.05 6.59 6.04 7.14 6.60 5.72 3.94 2.88 3.23
Inventory Turnover
1.98 2.49 1.96 2.39 4.09 3.68 2.88 2.64 2.49 2.75
Average Days of Payables
51.43 48.84 57.00 66.88 55.66 58.12 63.80 76.92 120.74 167.46
Days of Inventory on Hand
208.82 139.94 209.62 201.85 106.53 90.07 131.63 146.93 143.61 188.28
Average Receivables
3.60 2.98 1.97 2.23 2.25 1.72 1.28 1.14 1.17 0.86
Average Payables
2.38 2.30 2.06 1.81 1.48 1.29 1.22 1.47 1.81 1.28
Average Inventory
8.19 7.46 6.93 4.56 2.59 2.31 2.43 2.19 2.09 1.50
Average Assets
43.82 44.45 44.33 44.66 42.41 39.52 35.71 33.51 29.50 19.62
Average Common Equity
27.29 26.26 27.69 31.48 30.42 28.63 25.37 22.67 21.66 15.17

Fold the line items

Columns are period end dates